Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes.

Skogsberg J, Dicker A, Rydén M, Aström G, Nilsson R, Bhuiyan H, Vitols S, Mairal A, Langin D, Alberts P, Walum E, Tegnér J, Hamsten A, Arner P, Björkegren J.

PLoS One. 2008;3(11):e3771. doi: 10.1371/journal.pone.0003771. Epub 2008 Nov 20.

2.

The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.

Goldberg IJ, Wagner WD, Pang L, Paka L, Curtiss LK, DeLozier JA, Shelness GS, Young CS, Pillarisetti S.

J Biol Chem. 1998 Dec 25;273(52):35355-61.

3.

Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid.

Degrace P, Moindrot B, Mohamed I, Gresti J, Du ZY, Chardigny JM, Sébédio JL, Clouet P.

J Lipid Res. 2006 Dec;47(12):2647-55. Epub 2006 Sep 6.

4.

Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.

Johnson LA, Altenburg MK, Walzem RL, Scanga LT, Maeda N.

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1745-52. doi: 10.1161/ATVBAHA.108.169680. Epub 2008 Jul 10.

5.
6.

Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes-A possible role of betel-quid chewing in metabolic syndrome.

Hsu HF, Tsou TC, Chao HR, Shy CG, Kuo YT, Tsai FY, Yeh SC, Ko YC.

Toxicol Appl Pharmacol. 2010 Jun 15;245(3):370-7. doi: 10.1016/j.taap.2010.04.008. Epub 2010 Apr 18.

PMID:
20406654
7.

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.

Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.

Arterioscler Thromb Vasc Biol. 2006 Jun;26(6):1350-6. Epub 2006 Mar 30.

PMID:
16574893
8.

Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.

Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.

J Pharmacol Exp Ther. 2003 Jul;306(1):332-7. Epub 2003 Apr 8.

10.

The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.

Larsson SL, Skogsberg J, Björkegren J.

J Biol Chem. 2004 Jan 9;279(2):831-6. Epub 2003 Oct 28.

11.

Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.

Richard C, Couture P, Ooi EM, Tremblay AJ, Desroches S, Charest A, Lichtenstein AH, Lamarche B.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):433-8. doi: 10.1161/ATVBAHA.113.302185. Epub 2013 Nov 21.

PMID:
24265415
12.

Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.

Dichek HL, Johnson SM, Akeefe H, Lo GT, Sage E, Yap CE, Mahley RW.

J Lipid Res. 2001 Feb;42(2):201-10.

13.

FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets.

Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, Inoue K, Kitazawa R, Kitazawa S, Matsuki Y, Hiramatsu R, Masubuchi S, Omachi A, Kimura K, Saito M, Amo T, Ohta S, Yamaguchi T, Osumi T, Cheng J, Fujimoto T, Nakao H, Nakao K, Aiba A, Okamura H, Fushiki T, Kasuga M.

J Clin Invest. 2008 Aug;118(8):2808-21. doi: 10.1172/JCI34090.

14.

beta-adrenoceptor-stimulated lipolysis of subcutaneous abdominal adipocytes as a determinant of fat oxidation in obese men.

Imbeault P, Tremblay A, Després J, Mauriège P.

Eur J Clin Invest. 2000 Apr;30(4):290-6.

PMID:
10759876
15.

Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.

Nuotio-Antar AM, Hachey DL, Hasty AH.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1517-28. Epub 2007 Sep 18. Erratum in: Am J Physiol Endocrinol Metab. 2008 May;294(5):E993.

16.

Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.

Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D.

J Lipid Res. 2000 Feb;41(2):305-18.

17.
18.

An apolipoprotein B100 mimotope prevents obesity in mice.

Kim HJ, Lee HJ, Choi JS, Han J, Kim JY, Na HK, Joung HJ, Kim YS, Binas B.

Clin Sci (Lond). 2016 Jan;130(2):105-16. doi: 10.1042/CS20150423. Epub 2015 Oct 30.

19.

Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic dyslipidaemia.

Pettersson C, Fogelstrand L, Rosengren B, Ståhlman S, Hurt-Camejo E, Fagerberg B, Wiklund O.

J Intern Med. 2008 Aug;264(2):155-65. doi: 10.1111/j.1365-2796.2008.01932.x. Epub 2008 Feb 20.

20.

Substance P decreases fat storage and increases adipocytokine production in 3T3-L1 adipocytes.

Miegueu P, St-Pierre DH, Lapointe M, Poursharifi P, Lu H, Gupta A, Cianflone K.

Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G420-7. doi: 10.1152/ajpgi.00162.2012. Epub 2012 Dec 20.

Supplemental Content

Support Center